Authors


Brooke McCormick

Latest:

Methotrexate, Leflunomide Linked to Higher Risk of Adverse Pregnancy Outcomes in Patients With RA

Due to the increased possibility of adverse pregnancy outcomes associated with methotrexate and leflunomid, it is crucial that patients with rheumatoid arthritis (RA) engage in thorough consultations with their physicians regarding pregnancy planning.


Chris Aiken, MD

Latest:

Insomnia and Bipolar Disorder: New Directions

The average patient with bipolar disorder struggles with sleep disorders. Here's how you can help.


Alicia Warnock, M.D.

Latest:

Improve Patient Care and Chronic Disease Management

Healthcare professionals need to make patients the primary decision-makers in their own care and actively support their efforts to achieve their care goals.


Heather Haro

Latest:

The Good, The Bad, and the Missed Opportunity of Mark Cuban Cost Plus Drug Company

The billionaire’s first venture into pharmacy launched earlier this year.


Jay Ackerman

Latest:

Why Artificial Intelligence is Critical to the Success of Value-Based Care

Employing AI-driven technology ensures accurate and timely compliance with industry regulations, mitigates audits and fines, and helps forecast accurate reimbursements.


Connor Iapoce

Latest:

Examining Barriers to Care in Diabetic Retinopathy Screening

Prior research has shown the association between various socioeconomic variables and lower adherence to diabetic retinopathy screening, but few have elaborated on the patient perspective to understand the reason behind this association.


Kristi Rosa

Latest:

Mirvetuximab Soravtansine for FRα+ Platinum-Resistant Ovarian Cancer Gets Full FDA Approval

Mirvetuximab soravtansine-gynx (Elahere) was first granted FDA accelerated approval in November 2022.


Charles Lee, MD

Latest:

Why Patient Education Is More Important Than Ever

How pharmacists can address knowledge gaps and health literacy challenges to help people with chronic conditions stay adherent to drug therapies


Erin Smith

Latest:

Mind-Body Resilience for Women: A Focus on Depression

Developing innovative solutions for women with depression, accounting for differences in gender and sex, are critically important


Celeste Krewson

Latest:

Fish, Omega-3 Fatty Acid Intake Below Recommended Levels Among Pregnant Women

N-3 polyunsaturated fatty acids (PUFAs) are essential nutrients, especially during pregnancy as they support neurodevelopment in offspring and improve pregnancy outcomes.


Robert Busch, MD

Latest:

Bempedoic Acid for Hypercholesterolemia

An expert panel discusses where bempedoic acid currently fits into the treatment of hypercholesterolemia.


AJ Rivosecchi, PharmD

Latest:

Hospital Pharmacies and Budget Management: How Technology Can Help

The hospital pharmacy must play its part by leveraging technology to control the costs of doing business and supporting the enterprise in addition to focusing on patient care.


Jonathan Ogurchak, PharmD, CSP

Latest:

New Advances in Breast Cancer Therapy

Breast cancer continues to affect women globally, with approximately 13% developing invasive disease. New treatment regimens and options are on the horizon for breast cancer therapy.


Larry King, PharmD

Latest:

How Interoperability, Data Infrastructure Create New Opportunities for Pharmacies | NCPDP 2025

Larry King, PharmD, joins Drug Topics at NCPDP 2025 to discuss pharmacy interoperability, changes in its regulations, and how technology will fall into place within the data infrastructure.


Steven M. Selbst, MD

Latest:

Preventing Severe Respiratory Infections in Children

A refresher on best interventions for common respiratory disorders in children.


Denise Myshko

Latest:

ICER Finds Insurers Struggled to Provide Fair Access to Obesity Drugs

The Institute for Clinical and Economic Review assessed the formularies of 11 payers, covering 57 million people, to determine access to drugs that the organization had reviewed for cost effectiveness in 2022.


Allison Inserro

Latest:

COVID-19 National Emergencies to End in May

The public health emergency, which was set to end April 11, and the national emergency, which was set to end March 1, will be ended on May 11 by the Biden administration.



Antonella Santuccione Chadha, MD

Latest:

Mind-Body Resilience for Women: A Focus on Depression

Developing innovative solutions for women with depression, accounting for differences in gender and sex, are critically important


Don Creighton

Latest:

Inflation Reduction Act and Its Impact on Pharmaceutical Pricing and Investment Decisions

The reference to “maximum fair price” in the act bodes poorly for manufacturers and suggests more of a take-it-or-leave-it situation rather than a negotiation where clinical evidence would be the prevailing factor in determining price.


Jay Holloway, PharmD, AAHIVP

Latest:

HIV Care Creates Opportunities for Pharmacists to Expand Scope

In the most recent episode of Over the Counter, Jay Holloway, PharmD, AAHIVP, discussed advancements in HIV, especially regarding the role of pharmacists.


Jon Matthew Farber, MD

Latest:

How Vitamin D Can Help Migraines In Young Patients

Vitamin D supplementation may be an effective and safe adjunctive prophylactic therapy to topiramate for children who experience migraine attacks, showed a study conducted in Saudi Arabia.


Fazila Rajab, BDS

Latest:

Holistic Treatment Techniques for Managing Atopic Dermatitis

Patients are finding relief in alternative therapies for this chronic skin disease.


Meg Marzella

Latest:

Racial, Ethnic Inequities Persist in Diabetes Care

Significant differences in the use of insulin pump and/or CGM technology were noted based on demographic and socioeconomic factors


Hayley Virgil

Latest:

Bosutinib Approved by FDA for Pediatric Chronic Myelogenous Leukemia

Positive findings from the phase 1/2 BCHILD study supported the approval decision.


Noah Stansfield

Latest:

FDA Requests Black Box Warning for Approved CAR-T Therapies Over Secondary Cancer Concern

As per US law Section 505(o)(4), the manufacturers are required to make the requested changes, respond with a modified version of the requested changes for review, or respond with a rebuttal within 30 days of the FDA's ask.


Kyle Munz

Latest:

COVID-19 Vaccination Rates Significantly Lower in Patients With Sickle Cell Disease

Patients with SCD are more vulnerable to hospitalization due, in part, to SCD’s impact on the spleen, which filters infections in the blood and is a crucial organ for the immune system.


Clarice Holmes, RN

Latest:

Advanced Health Care Technology Solutions Can Help Both Providers and Payers

Integrating evidence-based treatment protocols through a streamlined approach enables the delivery of higher quality, comprehensive care.


Kelley Detweiler

Latest:

Veterinary Prescriptions Made Easy

How can e-prescribing improve the workflow between pharmacists and their veterinarian colleagues?


Sally Arif, PharmD

Latest:

Effective Communication Can Bridge Gaps in Care | APhA 2025

Sally Arif, PharmD, professor in the College of Pharmacy at Midwestern University, discusses how pharmacists can effectively communicate with diverse patients.

© 2025 MJH Life Sciences

All rights reserved.